Isan Chen
Founder at Mbrace Therapeutics, Inc.
Net worth: 3 M $ as of 29/04/2024
Isan Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
Mbrace Therapeutics, Inc.
 Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | Director/Board Member | 30/04/2020 | - |
| Chief Executive Officer | 30/04/2020 | - | |
| Founder | 30/04/2020 | - | |
| President | 30/04/2020 | - | |
Treadwell Therapeutics, Inc.
 Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Director/Board Member | - | - |
Career history of Isan Chen
Former positions of Isan Chen
| Companies | Position | Start | End |
|---|---|---|---|
| TYRA BIOSCIENCES, INC. | Director/Board Member | 31/01/2019 | 06/05/2024 |
| Independent Dir/Board Member | 31/01/2019 | 06/05/2024 | |
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 03/09/2013 | 17/05/2020 |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 31/12/2009 | 30/06/2013 |
| PFIZER, INC. | Corporate Officer/Principal | 31/12/2003 | 31/12/2009 |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Training of Isan Chen
| University of Sao Paulo | Doctorate Degree |
Statistics
International
| United States | 8 |
| Brazil | 2 |
Operational
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Mbrace Therapeutics, Inc.
Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | Health Technology |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Isan Chen
- Experience
